mesothelioma treatment

Clinical Trial Tests Drug Combination in Mesothelioma

UPDATE: Aduro Biotech announced on December 12 that they have decided to discontinue its CRS-207 clinical trial and wind down each of its trials in mesothelioma. This decision was made based on preliminary results from the trials, as well as a business and commercial assessment.
On November 8, 2017, the Meso Foundation hosted a Meet the Mesothelioma […]


Treating and Preventing a Cancer that Many are at Risk For But Few Know About

Anyone who has ever done any DIY-style home renovations and construction on a home built before the 80s may be at risk for mesothelioma.
Mesothelioma is a cancer usually associated with asbestos exposure. It is most often found in the lining of the lung or abdomen, and sometimes other organs as well.
It is a common misconception […]


Genentech Halts Avastin Approval Filing for Mesothelioma

In 2015, data was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting from a Phase III French study that demonstrated improved survival rates for patients who received bevacizumab (Avastin® Genentech, Inc.) in addition to the standard chemotherapy regimen of pemetrexed/cisplatin.
The outcome of the study prompted the independent French cooperative group and Genentech […]



Updates in Mesothelioma Research from ASCO 2017

The American Society of Clinical Oncology (ASCO) held its Annual Meeting on June 2-6, 2017 in Chicago. The Meso Foundation’s CEO, Melinda Kotzian, had the opportunity to attend the conference and hear the latest news reported in mesothelioma research.
Hedy Lee Kindler, MD, of the University of Chicago, presented a poster on the results from a […]